CG17249A362 heterozygosity has no significant effect in the adult locomotor capacity (in negative geotaxis assays) of 18 days old adults, as compared to controls.
CG17249[+]/CG17249A362 is an enhancer of abnormal locomotor behavior | adult stage | progressive phenotype of Hsap\APPAβ42.UAS.Tag:SS(rPENK), Scer\GAL4elav-C155
CG17249A362 heterozygosity enhances the adult locomotion defects induced by the expression of Hsap\APPAβ42.UAS.Tag:SS(rPENK) under the control of Scer\GAL4elav-C155.